ADMA Biologics Inc (ADMA):企業の財務・戦略的SWOT分析

◆英語タイトル:ADMA Biologics Inc (ADMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH250214FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ADMA Biologics Inc (ADMA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ADMA Biologics Inc (ADMA Biologics) is an integrated biopharmaceutical and specialty immunoglobulin company which develops, produces, and commercializes specialty biologics to treat immune deficiencies and prevent certain infectious diseases. The company develops RI-002, is a specialty plasma-derived, polyclonal, intravenous immune globulin, derived from human plasma containing naturally occurring polyclonal antibodies to treat Primary Immune Deficiency Disease. ADMA Biologics’ target treatment areas include bacterial infections, respiratory syncytial virus and primary immune deficiency diseases. It also operates bio centers which carry out plasma collection and offer blood plasma to manufacture the company’s products. ADMA Biologics is headquartered in Ramsey, New Jersey, the US.

ADMA Biologics Inc Key Recent Developments

Dec 09,2020: ADMA Biologics enters into $100 million credit facility loan amendment with perceptive advisors
Dec 01,2020: ADMA Biologics opens newest ADMA BioCenters plasma collection facility in Maryville, TN
Nov 05,2020: ADMA Biologics reports third quarter 2020 financial results and business highlights
Oct 21,2020: ADMA Biologics announces presentation on respiratory viral infections and new data on S. Pneumoniae at IDWeek 2020
Aug 05,2020: ADMA Biologics reports business highlights and second quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ADMA Biologics Inc – Key Facts
ADMA Biologics Inc – Key Employees
ADMA Biologics Inc – Key Employee Biographies
ADMA Biologics Inc – Major Products and Services
ADMA Biologics Inc – History
ADMA Biologics Inc – Company Statement
ADMA Biologics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ADMA Biologics Inc – Business Description
Product Category: License Revenue
Performance
Product Category: Product Revenue
Performance
Product Category: ADMA BioManufacturing
Overview
Performance
Product Category: Corporate
Performance
Product Category: Plasma Collection Center
Overview
Performance
R&D Overview
ADMA Biologics Inc – Corporate Strategy
ADMA Biologics Inc – SWOT Analysis
SWOT Analysis – Overview
ADMA Biologics Inc – Strengths
ADMA Biologics Inc – Weaknesses
ADMA Biologics Inc – Opportunities
ADMA Biologics Inc – Threats
ADMA Biologics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
ADMA Biologics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 09, 2020: ADMA Biologics enters into $100 million credit facility loan amendment with perceptive advisors
Dec 01, 2020: ADMA Biologics opens newest ADMA BioCenters plasma collection facility in Maryville, TN
Nov 05, 2020: ADMA Biologics reports third quarter 2020 financial results and business highlights
Oct 21, 2020: ADMA Biologics announces presentation on respiratory viral infections and new data on S. Pneumoniae at IDWeek 2020
Aug 05, 2020: ADMA Biologics reports business highlights and second quarter 2020 financial results
Jul 06, 2020: ADMA Biologics opens its newest ADMA BioCenters plasma collection facility
Jun 23, 2020: ADMA Biologics announces Martha J. Demski elected to Board of Directors
May 21, 2020: ADMA Biologics commences collection of COVID-19 Plasma from recovered patients
May 06, 2020: ADMA Biologics reports first quarter 2020 financial results and highlights recent company progress
Apr 16, 2020: ADMA Biologics receives funding under Paycheck Protection Program
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ADMA Biologics Inc, Key Facts
ADMA Biologics Inc, Key Employees
ADMA Biologics Inc, Key Employee Biographies
ADMA Biologics Inc, Major Products and Services
ADMA Biologics Inc, History
ADMA Biologics Inc, Subsidiaries
ADMA Biologics Inc, Key Competitors
ADMA Biologics Inc, Ratios based on current share price
ADMA Biologics Inc, Annual Ratios
ADMA Biologics Inc, Annual Ratios (Cont...1)
ADMA Biologics Inc, Interim Ratios
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
ADMA Biologics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ADMA Biologics Inc (ADMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • salesforce.com, inc.:企業のM&A・事業提携・投資動向
    salesforce.com, inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's salesforce.com, inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Fortis Healthcare Ltd (FORTIS):企業の財務・戦略的SWOT分析
    Fortis Healthcare Ltd (FORTIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Taseko Mines Limited:企業の戦略・SWOT・財務情報
    Taseko Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Taseko Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Idemitsu Kosan Co., Ltd.:企業の戦略・SWOT・財務情報
    Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Westinghouse Air Brake Technologies Corporation:企業のM&A・事業提携・投資動向
    Westinghouse Air Brake Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westinghouse Air Brake Technologies Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descript …
  • ProAxsis Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • XenoPort Inc-製薬・医療分野:企業M&A・提携分析
    Summary XenoPort Inc (XenoPort) is a bio-pharmaceutical company which develops and commercializes internally discovered product candidates for the treatment of neurological disorders. It develops Transported Prodrugs through the modification of chemical structure of existing drugs in the market. The …
  • Propanc Biopharma Inc (PPCB):製薬・医療:M&Aディール及び事業提携情報
    Summary Propanc Biopharma Inc (Propanc), formerly Propanc Health Group Corp, is a clinical stage biopharmaceutical company, which manufactures products for the treat of metastatic, pancreatic, ovarian and colorectal cancers. The company’s lead product candidate, PRP, a once-a-day intravenous formula …
  • Mediware Information Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Toro Energy Limited (TOE):企業の戦略的SWOT分析
    Toro Energy Limited (TOE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Fluidigm Corp (FLDM)-製薬・医療分野:企業M&A・提携分析
    Summary Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, ca …
  • Nolato AB (NOLA B):企業の財務・戦略的SWOT分析
    Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Far East Hotels And Entertainment Limited:企業の戦略・SWOT・財務分析
    Far East Hotels And Entertainment Limited - Strategy, SWOT and Corporate Finance Report Summary Far East Hotels And Entertainment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Sanyo Electric Co Ltd:企業のM&A・事業提携・投資動向
    Sanyo Electric Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sanyo Electric Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • ICA Gruppen AB:企業の戦略・SWOT・財務情報
    ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report Summary ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Global Clean Energy Holdings Inc:企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Meritor, Inc. (MTOR):企業の財務・戦略的SWOT分析
    Meritor, Inc. (MTOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Essar Power Limited-エネルギー分野:企業M&A・提携分析
    Summary Essar Power Limited (Essar Power), a subsidiary of Essar Energy Limited, is a power utility which produces electricity and thermal energy. It generates power from coal, natural gas, and co-generation plants. The company owns and operates power generation plants in India and Canada. Through i …
  • Johnson & Johnson (JNJ)-製薬・医療分野:企業M&A・提携分析
    Summary Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infec …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆